entrophen chewable tablet (chewable)
pendopharm division of pharmascience inc - acetylsalicylic acid - tablet (chewable) - 81mg - acetylsalicylic acid 81mg - salicylates
enteric coated daily low dose asa 81 mg tablet (delayed-release)
vita health products inc - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
asa 81 mg tablet (delayed-release)
vita health products inc - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
rivasa 81 mg ec tablet (delayed-release)
laboratoire riva inc. - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
jamp-asa 81mg ec tablet (enteric-coated)
vita health products inc - acetylsalicylic acid - tablet (enteric-coated) - 81mg - acetylsalicylic acid 81mg - salicylates
asa 81 mg tablet (delayed-release)
laboratoires trianon inc. - acetylsalicylic acid - tablet (delayed-release) - 81mg - acetylsalicylic acid 81mg - salicylates
acetylsalicylic acid krka 100 mg gastro-resist. tabl.
krka d.d. novo mesto d.d. - acetylsalicylic acid 100 mg - gastro-resistant tablet - 100 mg - acetylsalicylic acid 100 mg - acetylsalicylic acid
anadin analgesic film-coated tablets aspirin 325mg caffeine 15mg
glaxosmithkline consumer healthcare (ireland) limited - aspirin; caffeine - film-coated tablet - 325/15 milligram(s) - salicylic acid and derivatives; acetylsalicylic acid, combinations excl. psycholeptics
clopidogrel / acetylsalicylic acid mylan
mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
fiorinal capsule
aralez pharmaceuticals canada inc - butalbital; caffeine; acetylsalicylic acid - capsule - 50mg; 40mg; 330mg - butalbital 50mg; caffeine 40mg; acetylsalicylic acid 330mg - barbiturates